Results 11 to 20 of about 88,897 (275)

Seroprevalence of Toxoplasma gondii and its associated risk factors among women of reproductive age in Saudi Arabia: a systematic review and meta-analysis

open access: yesInternational Journal of Women's Health, 2018
Riyadh A Alzaheb Department of Clinical Nutrition, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk, Saudi Arabia Abstract: Toxoplasma gondii (T.
Alzaheb RA
core   +1 more source

SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021

open access: yesBMJ Global Health, 2022
Introduction Estimating COVID-19 cumulative incidence in Africa remains problematic due to challenges in contact tracing, routine surveillance systems and laboratory testing capacities and strategies.
  +90 more
doaj   +1 more source

Seroprevalence of antibodies to SARS-CoV-2 among blood donors in the early months of the pandemic in Saudi Arabia

open access: yesInternational Journal of Infectious Diseases, 2021
Background: Serologic testing provides better understanding of SARS-CoV-2 prevalence and its transmission. This study was an investigation of the prevalence of antibodies to SARS-CoV-2 among blood donors in Saudi Arabia.
Ayman Banjar   +21 more
doaj   +1 more source

Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020–June 30, 2022

open access: yesEmerging Infectious Diseases, 2023
We estimated SARS-CoV-2 seroprevalence in children in Oregon, USA, at 6 time points. Seroprevalence increased linearly during November 2020–December 2021 and peaked in February 2022 at 38.8% (95% CI 32.8%–46.5%).
Rebecca A. Falender   +4 more
doaj   +1 more source

Heterogeneous evolution of SARS-CoV-2 seroprevalence in school-age children

open access: yesSwiss Medical Weekly, 2023
BACKGROUND: Much remains unknown regarding the evolution of SARS-CoV-2 seroprevalence and variability in seropositive children in districts, schools and classes as only a few school-based cohort studies exist.
Sarah R. Haile   +6 more
doaj   +1 more source

Seroprevalence of Noroviruses in Swine [PDF]

open access: yesJournal of Clinical Microbiology, 2005
ABSTRACT Noroviruses (NVs) are important human pathogens that cause acute gastroenteritis. Genetically related animal enteric NVs have also been described, but there is no evidence of interspecies transmission of NVs. In this study we characterized antibody prevalence among domestic pigs by using recombinant capsid antigens of two human NVs ...
Tibor, Farkas   +5 more
openaire   +2 more sources

Confidence Intervals for Seroprevalence

open access: yesStatistical Science, 2022
This paper concerns the construction of confidence intervals in standard seroprevalence surveys. In particular, we discuss methods for constructing confidence intervals for the proportion of individuals in a population infected with a disease using a sample of antibody test results and measurements of the test's false positive and false negative rates.
DiCiccio, Thomas J.   +3 more
openaire   +2 more sources

Seroprevalence of Trypanosoma evansi in camels using CATT/T. evansi technique in Borno and Yobe states, Nigeria

open access: yesParasite Epidemiology and Control, 2021
Trypanosoma evansi is an important camel pathogen with dissimilar mammalian hosts and is the most widely distributed pathogenic animals' trypanosomes worldwide that affects domesticated animals.
Falmata Kyari, PhD   +4 more
doaj   +1 more source

Surveillance of SARS-CoV-2 antibodies of patients in the local affected area during Wuhan lockdown

open access: yesBMC Infectious Diseases, 2022
Highlights 1. Two months after the COVID-19 outbreak in Wuhan, the seroprevalence for IgM and IgG in the convalescent patients was 31.82% and 77.27%, respectively.
Yueting Tang   +10 more
doaj   +1 more source

Adeno‐associated virus serotype 2 capsid variants for improved liver‐directed gene therapy

open access: yesHepatology, EarlyView., 2022
Abstract Background and Aims Current liver‐directed gene therapies look for adeno‐associated virus (AAV) vectors with improved efficacy. With this background, capsid engineering is explored. Whereas shuffled capsid library screenings have resulted in potent liver targeting variants with one first vector in human clinical trials, modifying natural ...
Nadja Meumann   +25 more
wiley   +1 more source

Home - About - Disclaimer - Privacy